212 related articles for article (PubMed ID: 11734186)
1. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray.
De Araújo JE; Huston JP; Brandão ML
Eur J Pharmacol; 2001 Nov; 432(1):43-51. PubMed ID: 11734186
[TBL] [Abstract][Full Text] [Related]
2. Anxiogenic effects of substance P and its 7-11 C terminal, but not the 1-7 N terminal, injected into the dorsal periaqueductal gray.
De Araújo JE; Silva RC; Huston JP; Brandão ML
Peptides; 1999 Dec; 20(12):1437-43. PubMed ID: 10698119
[TBL] [Abstract][Full Text] [Related]
3. Place aversion induced by microinjections of C-fragment of substance P into the dorsal periaqueductal gray of rats is mediated by tachykinin NK1 receptors.
De Araújo JE; Huston JP; Brandão ML
Peptides; 2001 Sep; 22(9):1447-52. PubMed ID: 11514027
[TBL] [Abstract][Full Text] [Related]
4. Blockade of mu- and activation of kappa-opioid receptors in the dorsal periaqueductal gray matter produce defensive behavior in rats tested in the elevated plus-maze.
Nobre MJ; Ribeiro dos Santos N; Aguiar MS; Brandão ML
Eur J Pharmacol; 2000 Sep; 404(1-2):145-51. PubMed ID: 10980273
[TBL] [Abstract][Full Text] [Related]
5. Behavioral sensitization induced by dorsal periaqueductal gray electrical stimulation is counteracted by NK1 receptor antagonism in the ventral hippocampus and central nucleus of the amygdala.
Carvalho MC; Veloni AC; Genaro K; Brandão ML
Neurobiol Learn Mem; 2018 Feb; 148():60-68. PubMed ID: 29519453
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic effect of a CRH receptor antagonist in the dorsal periaqueductal gray.
Martins AP; Marras RA; Guimarães FS
Depress Anxiety; 2000; 12(2):99-101. PubMed ID: 11091933
[TBL] [Abstract][Full Text] [Related]
7. The neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injection.
Nikolaus S; Huston JP; Hasenöhrl RU
Neuroreport; 1999 Aug; 10(11):2293-6. PubMed ID: 10439451
[TBL] [Abstract][Full Text] [Related]
8. Aversive effects of the C-fragment of Substance P in the dorsal periaqueductal gray matter.
de Araújo JE; Huston JP; Brandão ML
Exp Brain Res; 1998 Nov; 123(1-2):84-9. PubMed ID: 9835395
[TBL] [Abstract][Full Text] [Related]
9. Anxiogenic effect of corticotropin-releasing hormone in the dorsal periaqueductal grey.
Martins AP; Marras RA; Guimarães FS
Neuroreport; 1997 Nov; 8(16):3601-4. PubMed ID: 9427334
[TBL] [Abstract][Full Text] [Related]
10. Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test.
Aguiar MS; Brandão ML
Physiol Behav; 1996 Oct; 60(4):1183-6. PubMed ID: 8884951
[TBL] [Abstract][Full Text] [Related]
11. Anxiolytic-like effect of noradrenaline microinjection into the dorsal periaqueductal gray of rats.
Pelosi GG; Resstel LL; Soares VP; Zangrossi H; Guimarães FS; Corrêa FM
Behav Pharmacol; 2009 May; 20(3):252-9. PubMed ID: 19407657
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the effects of morphine in the dorsal periaqueductal gray and nucleus accumbens of rats submitted to the elevated plus-maze test.
Anseloni VC; Coimbra NC; Morato S; Brandão ML
Exp Brain Res; 1999 Nov; 129(2):260-8. PubMed ID: 10591900
[TBL] [Abstract][Full Text] [Related]
13. Evidence for mediation of nociception by injection of the NK-3 receptor agonist, senktide, into the dorsal periaqueductal gray of rats.
Bassi GS; Broiz AC; Gomes MZ; Brandão ML
Psychopharmacology (Berl); 2009 May; 204(1):13-24. PubMed ID: 19093101
[TBL] [Abstract][Full Text] [Related]
14. Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor.
Nikolaus S; Huston JP; Hasenöhrl RU
Eur J Pharmacol; 1999 Apr; 370(2):93-9. PubMed ID: 10323256
[TBL] [Abstract][Full Text] [Related]
15. Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice.
Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
Behav Brain Res; 2013 Aug; 250():308-15. PubMed ID: 23707246
[TBL] [Abstract][Full Text] [Related]
16. Dorsal periaqueductal gray post-stimulation freezing is counteracted by neurokinin-1 receptor antagonism in the central nucleus of the amygdala in rats.
Carvalho MC; Santos JM; Brandão ML
Neurobiol Learn Mem; 2015 May; 121():52-8. PubMed ID: 25883049
[TBL] [Abstract][Full Text] [Related]
17. Further evidence on the anxiogenic-like effect of substance P evaluated in the elevated plus-maze in rats.
Duarte FS; Testolin R; De Lima TC
Behav Brain Res; 2004 Oct; 154(2):501-10. PubMed ID: 15313039
[TBL] [Abstract][Full Text] [Related]
18. Hyperanxiety produced by periaqueductal gray injection of chondroitin sulphate glycosaminoglycan.
De Araujo JE; Hasenöhrl RU; Huston JP; Brandão ML
Neuroreport; 2001 Oct; 12(14):3081-4. PubMed ID: 11568641
[TBL] [Abstract][Full Text] [Related]
19. Effects of neurokinin-1 and 3-receptor antagonists on the defensive behavior induced by electrical stimulation of the dorsal periaqueductal gray.
Broiz AC; Bassi GS; De Souza Silva MA; Brandão ML
Neuroscience; 2012 Jan; 201():134-45. PubMed ID: 22123168
[TBL] [Abstract][Full Text] [Related]
20. Galanin microinjection into the dorsal periaqueductal gray matter produces paradigm-dependent anxiolytic effects.
Soares FR; Silote GP; Almeida-Santos AF; Aguiar DC; Schenberg LC; Beijamini V
Brain Res Bull; 2016 Mar; 121():42-7. PubMed ID: 26751815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
